MEDICINAL cannabis is seen as one of the next big growth areas for pharmaceutical products - and not just for humans.
Auckland-based Helius Animal Health has announced the development of what is hoped to become the world's first registered CBD oils for pets.
New Zealand's recently launched Medicinal Cannabis Scheme allows for local cannabis production, with Helius MD Leila de Koster saying "CBD is highly effective for treating the likes of pain and inflammation in humans, and it's no different for animals."
"They have an endogenous cannabinoid system just like us, meaning cannabis therapeutics work in a similar way for pets."
Paul Manning, CEO of parent company Helius Therapeutics, said "to have high-quality, locally-produced therapeutic cannabis products readily available in New Zealand will be a game-changer for many Kiwi pet owners desperate to alleviate their companion's pain and suffering naturally".
The first product expected to launch is a CBD extract for osteoarthritis pain management in dogs, the company forecast.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Jul 21
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Jul 21
